Drug Search Results
More Filters [+]

Rotigotine

Alternative Names: rotigotine, neupro, spm 962, n-0923, ly-03003, ly 03003, ly03003
Latest Update: 2024-12-05
Latest Update Note: News Article

Product Description

Rotigotine is a non-ergot dopamine agonist that has been developed as a new transdermal formulation, and is indicated for use in early (USA and Europe) and advanced (Europe only) Parkinson's disease (PD). (Sourced from: https://pubmed.ncbi.nlm.nih.gov/19239399/)

Mechanisms of Action: DR Agonist,D2 Agonist,D3 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Transdermal

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | Indonesia | Ireland | Italy | Japan | Jordan | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Mexico | Netherlands | New Zealand | Norway | Peru | Poland | Portugal | Romania | Russia | Saudi Arabia | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: UCB
Company Location: SMYRNA GA 30080
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Rotigotine

Countries in Clinic: China

Active Clinical Trial Count: 6

Highest Development Phases

Phase 3: Parkinson's Disease|Restless Legs Syndrome

Phase 2: Sleep Apnea, Obstructive|Sleep Bruxism

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2018-001445-13

P3

Completed

Restless Legs Syndrome

2023-07-26

CTR20221398

P1

Completed

Parkinson's Disease

2022-12-12

LY03003/CT-CHN-304

P3

Completed

Parkinson's Disease

2022-03-17

95%

STRIVE

P2

Active, not recruiting

Sleep Apnea, Obstructive|Sleep Bruxism

2021-04-12

Recent News Events